Deal Type

Belgium-based private equity investor, Gimv, is taking a significant stake in Ambulantis, a Germany-based group of outpatient care facilities, in support of a growth plan...

PAI Partners backed Vamed Care has acquired the rehabilitation clinics of Paracelsus, with the aim of creating a leading provider of rehabilitation in Germany...

Om May 1, Brussels-listed real estate investor, Cofinimmo, has been approached by Brussels-listed healthcare real estate investor, Aedifica, concerning a conditional voluntary exchange offer. The Cofinimmo...

Switzerland-based multinational pharma, Novartis, has agreed to acquire Regulus Therapeutics, a publicly traded US-based clinical-stage biopharmaceutical company focused on developing microRNA therapeutics. Novartis will commence...

Healthcare Holding Schweiz, a Winterberg Group-backed buy, build & technologize platform and a leading provider of medical technology products and services in Switzerland, has...

Fremman Capital is acquiring Amethyst Healthcare Group, a European cancer care provider, from its founding shareholders and US investment firm, The Rohatyn Group (TRG). Founded...

Mérieux Equity Partners (MxEP), a France-based investment firm specialising in the healthcare sector, has announced the first closing of its Innovation fund, Mérieux Innovation...

DAX-listed Merck, a Germany-based global science and technology company, is acquiring Nasdaq-listed SpringWorks Therapeutics, a commercial-stage biopharmaceutical company focused on severe rare diseases and...

Granite Bio, a Switzerland-based clinical-stage immunology company, has emerged from stealth with US$100m in funding, which includes a US$30m Series A led by founding...

Veraxa Biotech, a drug discovery and development engine for antibody-drug conjugates (ADCs) and novel antibody-based therapy concepts, and Voyager Acquisition Corp, a US$253m Nasdaq-listed...